Artificial Intelligence–Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Patient Insights on Online Symptom Assessment Tools Utilizing Artificial Intelligence for Diagnosing Systemic Lupus Erythematosus

  • By

  • Olivia A. Stein

  • Jennifer L. F. Lee

  • Evelyne Vinet

  • Arielle Mendel

  • Christian A. Pineau

  • Fares Kalache

  • Louis-Pierre Grenier

  • Sasha Bernatsky

  • May 28, 2026

Share

Patient Insights on Online Symptom Assessment Tools Utilizing AI for SLE

Overview

This study explores patient perspectives on AI symptom assessment tools for diagnosing systemic lupus erythematosus (SLE). It highlights the challenges of timely diagnosis.

Background

Timely diagnosis of systemic lupus erythematosus (SLE) is complicated by heterogeneous symptoms and healthcare access issues, often leading to significant delays in diagnosis. Many patients experience prolonged periods of unrecognized symptoms, which can result in severe disease progression and mental distress. Understanding patient insights on AI tools may inform future developments in diagnostic pathways for complex conditions like SLE.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

  • Patients reported significant delays in receiving an SLE diagnosis, often due to misattribution of symptoms and healthcare access barriers.
  • AI symptom assessment tools may offer potential benefits but also have limitations in addressing the complexities of SLE.
  • Focus group discussions revealed that patients are often unaware of available online tools that could assist in their diagnostic journey.
  • Participants expressed concerns about the accuracy and reliability of AI tools in the context of their unique symptoms.
  • There is a need for AI tools to be tailored specifically for chronic complex diseases rather than general symptom assessment.

Clinical Implications

Healthcare providers should recognize the limitations and patient concerns regarding AI symptom assessment tools.

Conclusion

The study emphasizes the importance of understanding patient experiences with AI tools in the context of SLE diagnosis. Insights gained may guide future improvements in these technologies to better meet patient needs.

Related Resources & Content

  1. Kapsala et al., 2024 -- Patient Insights on Online Symptom Assessment Tools Utilizing AI for Diagnosing SLE
  2. Clinical Rheumatology — Artificial Intelligence Applications in Psoriatic Disease: Present Understanding and Prospective Developments
  3. Frontiers in Digital Health — Using objective measures of physical activity, sleep, and breathing for disease profiling of patients with systemic lupus erythematosus and Sjögren's disease
  4. Clinical Rheumatology — Best Practices and Key Considerations for Dermatologists and Rheumatologists in Managing Psoriatic Arthritis via Telemedicine
  5. JAMA Dermatology — Consumer Understanding of Skin Concerns With an AI-Powered Informational Tool
  6. EULAR/ACR classification criteria for SLE - PubMed
  7. Factors associated with delay in the diagnosis and treatment of systemic lupus erythematosus in adult patients: a systematic review | Rheumatology | Oxford Academic
  8. Accuracy of online symptom assessment applications, large language models, and laypeople for self–triage decisions | npj Digital Medicine

Original Source(s)

Related Content